Cochlear implants (CIs) have transformed the lives of over one million individuals with hearing impairment, including children as young as nine months. This systematic review critically examines the current literature on the application of…
Continue Reading
We reviewed 1016 FDA authorizations of AI/ML-enabled medical devices to develop a taxonomy capturing key variations in clinical and AI-related features. Quantitative image analysis remains the most common application, but its relative proportion has…
Continue Reading
Jai Pillai, COO of Red Sky Health
In the complex and often frustrating world of healthcare billing, claim denials, underpayments, and repeated resubmissions are among the most persistent and costly challenges faced by providers. The…
Continue Reading
Sepsis accounts for a substantial portion of global deaths and healthcare costs. The objective of this reproducibility study is to validate Duke Health’s Sepsis Watch ML model, in a new community healthcare setting and…
Continue Reading
Thalassemia is an inherited blood disorder. Current diagnostic methods mainly rely on sophisticated equipment and specifically trained technicians. This study aims to identify and genotype thalassemia by applying machine learning (ML) algorithms to routine…
Continue Reading
In acute ischemic stroke due to large-vessel occlusion (AIS-LVO), late-window endovascular thrombectomy (EVT) decisions depend on penumbra-to-core (P:C) mismatch from computed tomographic perfusion (CTP). We developed multiple machine learning (ML) models to predict P:C…
Continue Reading
This project represents the first systematic assessment of the US Food and Drug Administration’s postmarket surveillance of legally marketed artificial intelligence and machine learning based medical devices. We focus on the Manufacturer and User…
Continue Reading
Federated learning (FL) is advancing cancer research by enabling privacy-preserving collaborative training of machine learning (ML) models on diverse, multi-centre data. This systematic review synthesises current knowledge on state-of-the-art FL in oncology, focusing on…
Continue Reading
Israeli startup PhaseV, an AI-enabled clinical development company for life sciences, has secured $50 million in Series A funding in a round co-led by Accel and Insight Partners. Existing investors Viola Ventures, LionBird and EXOR…
Continue Reading
What You Should Know:
– PhaseV, a company at the forefront of applying artificial intelligence (AI) and machine learning (ML) to clinical development raies $50M in Series A funding round co-led by Accel and Insight…
Continue Reading
